|
GENETICS and GENETECHNOLOGY
|
Yet
another gene linked to higher schizophrenia risk (09/27/06)
The numer of genes linked to schizophrenia keep on growing.
Infants with a certain immune gene have a higher risk of schizophrenia
if it very closely match the mothers', American researchers say.
The findings suggest that schizophrenia risk rises most in daughters.
The gene is called HLA-B and infants inherit one copy from each
parent. HLA-B is one of a family of
genes which help the immune system distinguish between the body's
own proteins from those made by foreign organisms like viruses and
bacteria.
Source: The Copenhagen Post, Thursday, August 10, and Proceedings
of National Academy of Sciences, 103(33), p. 12469-74, 2006
Read
more in article at www.redorbit.com
PubMed
abstract
Gene
involved in the development of the brain may play a role in schizophrenia
(09/25/06)
Earlier research has suggested that schizophrenia is associated
with changes in myelin, the fatty substance in the brain that coats
nerve fibers and is critical for the brain to function properly.
Myelin is formed by a group of central nervous cells called oligodendrocytes,
which are regulated by a gene called OLIG2. Now a research team
has found that changes in the OLIG2 gene may play a causal role
in the development of schizophrenia.
Source: The Copenhagen Post, Thursday, August 10, and Proceedings
of National Academy of Sciences, 103(33), p. 12469-74, 2006
Read
more in article at www.innovations-report.org
PubMed
abstract
Scientists
have pinpointed two genes that may lead to schizophrenia and bipolar
disorder (09/25/06)
Danish researchers have discovered two risk genes for mental
illness, particularly schizophrenia and bipolar disorder (formerly
called manic depression). The research team identified the genes
on chromosome 22 in a research project in which persons from Scotland
and the Faeroe Islands participated. The team found that the patients
who showed signs of mental illness had mutations in the two genes
on that chromosome, GPR24 and BRD1. The discovery does not mean,
however, that the mutations in the two genes automatically result
in mental illness; there are numerous environmental factors also
at work.
Source: The Copenhagen Post, Thursday, August 10, and Molecular
Psychiatry, Aug 22, [Epub ahead of print], 2006
Read
more in article at www.cphpost.org
PubMed
abstract
Protein
in the cell nucleys may play a role in schizophrenia (07/19/06)
American researchers have discovered that a protein called Elk-1
interacts with mitochondria, the energy storehouse of a cell, suggesting
that this protein, active in the cell's nucleus, which contains
the DNA, could play a role in cell death and mitochondria-related
diseases such as neurodegeneration and schizophrenia.
Source: EurekAlert, Wednesday, June 7, and Nature Methods, v.
3(6), p. 455-60, 2006
Read
more in article at www.eurekalert.org
PubMed
abstract
Schizophrenic
mice lead the way (02/23/06)
Scientists say they have developed a mouse model of schizophrenia,
which could be useful in studies of this disease that affects about
one percent of the population.
The genetically manipulated mice have abnormal activity of the dopamine
machinery in a specific area of the brain, which results in cognitive
and behavioural changes similar to those obseved among people with
schizophrenia.
Source: Health 24 and Innovations Report, Thursday, February
16, and Neuron, v. 49(4), p. 603-615, 2006
Read
more in article at www.health24.com
Read
more in article at www.innovations-report.com
PubMed
abstract
New
mouse model could help explain the mechanisms behind schizophrenia
(02/05/06)
Removing a single gene in the mouse genome, which codes for
a protein - NR1 - involved in passing signals between nerve cells,
a process used in learning and memory, affects the mice in a way
that resembles schizophrenia in humans. When drugs are used to block
a similar protein to NR1 in humans, it results in a psychotic state.
The authors think both their genetic mouse model, as well as a new
learning and memory test they have developed may become useful for
studies of schizophrenia.
Source: GJ Sentinel, Friday, January 20, and Journal of Neurooscience,
v. 26(3), p. 908-15, 2006
Read
more in article at www.gjsentinel.com
PubMed
abstract
Children with
deletion syndrome confirm gene's role in psychosis (10/30/05)
An American study shows that children suffering from a deletion
syndrom, in which a part of chomosome 22 is missing, are at higher
risk of developing schizophrenia. The gene, in which the deletion
is located, codes for en enzyme called COMT, which is involved in
the production of the neurotransmitters dopamine, epinephrine and
norepinephrine. People suffering from the deletion syndrom are more
prone to cognitive decline, psychosis and loss of brain tissue in
the frontal lobe by late adolescence, when schizophrenia symptoms
usually begin to emerge.
Source: EurekAlert, Sunday, October 23, and Nature Neurooscience,
v.8(11), p. 1200-2, 2005
Read
more in article at www.eurekalert.org
PubMed
abstract
Link found between gene
important for the central nervous system and autism and schizophrenia
(10/15/05)
Researchers have unveiled new information
regarding the genetic, cellular and neurological bases of susceptibility
to complex diseases, such as autism and schizophrenia. By analyzing
data on 518 families, each with multiple autistic children, the
researchers discovered that there is a link between autism, and
probably also schizophrenia, and Engrailed 2 (EN2), a gene important
in the development of the central nervous system.
Source: Science Daily, Friday, October 7, and American Journal
of Human Genetics, v. 77, p. 851-868, 2005
Read
more in article at www.sciencedaily.com
Abstract
at the journal's homepage
Altered gene may increase schizophrenia risk (04/26/05)
A
new imaging study shows that a tiny variation in the gene that makes
the enzyme that breaks down dopamine, a neurotransmitter known to
be involved in schizophrenia, alters the dopamine activity in two
areas in the front of the brain.
Source: Innovations Report, Friday, April 22, , and Nature Neuroscience,
April 10; [Epub ahead of print], 2005
Read
more in article at www.innovations-report.com
PubMed
abstract
Could
schizophrenia arise from a single defect?
(02/25/05)
Researchers have agreed that schizophrenia
is a complex developmental disease caused by multiple factors, for
instance genes, prenatal trauma, and/or viral infections. It also
has several symptoms, like hallucinations, delusions, paranoia,
and antisocial behavior. Now a group of researchers suggest that
seemingly diverse combinations of symptoms can arise from a subtle
imbalance in the activity of a single gene whose protein plays a
key role in the development of the nervous system.
Source: EurekAlert, Wednesday, February 16, Ashbury
Park Press, Tuesday, Fenruary 22,
and Neuron, v. 45(4), p. 497-503, 2005
Read
more in article at www.eurekalert.org
Read
more in article at www.app.com
PubMed
abstract
New
discoveries concerning dopamine and schizophrenia (02/25/05)
One of the neurotransmitters involved
in schizophrenia is dopamine, which binds to receptors in the brain.
Now research shows that mutations in genes that have no relation
to the brains dopamine receptors can still cause those receptors
to become highly sensitive to dopamine, which leads to psychosis.
Source: Innovations Report, Tuesday, February 15, 2005, and Proc
Natl Acad Sci U S A. 2005 Feb 16, 2005
Read
more in article at www.innovations-report.de
PubMed
abstract
Discovery
of new gene may lead to antipsychotic treatment with fewer side
effects (12/07/04)
Because
of severe side effects, many
patients do not like to take the antipsychotic drugs prescribed
for schizophrenia. Australian
scientists now say they have discovered a gene that could significantly
improve the treatment of schizophrenic patients. The gene, they
say, makes patients more susceptible to the side effects of medication.
The new discoveries will make it possible for physicians to do a
simple blood test or DNA swab and predict what patinets will benefit
better from what typer of medications.
Source: ABC News Online, Thursday, December 2, 2004, and Schizophrenia
Research, v. 73(1), p. 31-7, 2005
Read
more in article at www.abc.net.au
PubMed
abstract
New
gene found associated with schizophrenia found (10/29/04)
A research team recently reported, at
the annual meeting of the Society for Neuroscience in San Diego,
that they have found a new gene called RGS4 may be associated with
schizophrenia. It is known that the gene is involved in the control
of the release of neurotransmitters, molecules that help nerve cells
communicate with each other. The research shows that patients with
schizophrenia have lower levels of
the protein that the RGS4 gene codes for.
Source: EurekAlert,
Wednesday, October 27, and Science Daily, Monday, Npovember 8, 2004
Read
more in article at www.eurekalert.org
Read
more in article at www.sciencedaily.com
Psychotic
mice may help researchers learn mora about schizophrenia (09/05/04)
American researchers have created a mouse
strain that display psychotic symptoms. The mice have mutations
in two genes called NPAS1
and NPAS3. These mutations are
also found in a Canadian family with a history of schizophrenia.
The mice have the same deficits that schizophrenic patients have.
Source: Reuters,
Monday, August 30, 2004
Read
more in article at www.reuters.co.uk
Glutamate
gene linked to schizophrenia identified (08/13/04)
Researchers have identified a relationship
between a small section of a gene for glutamate, a chemical signal
substance in the brain, known to be associated with schizophrenia.
Source: News-Medical.Net,
Wednesday, August 11, 2004
Read
more in article at www.news-medical.net
Australian
study have found 69 genes linked to schizophrenia (06/10/04)
Researchers
at the Melbourne Mental Health Research Institute have been collecting
tissue from brains from diceased patients, and have isolated 69
genes which may hold the key to both schizophrenia and bipolar disorder.
Source: The Australian,
Tuesday, June 8, and PR Newswire, Monday, June 7, 2004
Read
more in article at www.theaustralian.com.au
Read
more in article at www.prnewswire.com
Survival
gene linked to schizophrenia (04/17/04)
Approximately 2 percent of Caucasians
have a gene segment variation that can cause a certain form of schizophrenia.
Most people with this genetic variation do not have the disease.
A research team has now found that this mutation is associated with
general benefits for human survival.
Source: Science Blog,
Monday, April 12, 2004
Read
more in article at www.scienceblog.com
Studies
in yeast help researchers learn more about genetic mechanisms in
schizophrenia (02/07/04)
Different combinations of genetic mutations
may give rise to diverse human traits, including complex diseases
such as schizophrenia. Studies in yeast may help researchers learn
more about the mechanisms behind these diseases.
Source: news@UofT,
Thursday, February 5, 2004
Read
more in article at www.newsandevents.utoronto.ca
Several
genes operate differently in schizophrenic patients (01/17/04)
An Australian genetics study recently
showed that out of the 12 000 genes that were studied, 153 operate
differently in schizophrenic patients than in healthy individuals.
Source: The Age,
Friday, January 16, 2004
Read
more in article at www.theage.com.au
Previous
research news items in the category "genetics and genetechnology"
Back to indexpage for research |
|